Colin Mc Hugh Net Worth

The estimated Net Worth of Colin Mc Hugh is at least $210 millier dollars as of 3 September 2024. Colin Hugh owns over 1,534 units of Accolade stock worth over $210,299 and over the last few years Colin sold ACCD stock worth over $0.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

Colin Hugh ACCD stock SEC Form 4 insiders trading

Colin has made over 15 trades of the Accolade stock since 2023, according to the Form 4 filled with the SEC. Most recently Colin exercised 1,534 units of ACCD stock worth $5,998 on 3 September 2024.

The largest trade Colin's ever made was exercising 17,898 units of Accolade stock on 11 June 2024 worth over $69,981. On average, Colin trades about 2,253 units every 27 days since 2023. As of 3 September 2024 Colin still owns at least 53,785 units of Accolade stock.

You can see the complete history of Colin Hugh stock trades at the bottom of the page.

What's Colin Hugh's mailing address?

Colin's mailing address filed with the SEC is C/O ACCOLADE, INC., 1201 3RD AVE, SUITE 1700, SEATTLE, WA, 98101.

Insiders trading at Accolade

Over the last 4 years, insiders at Accolade have traded over $9,006,680 worth of Accolade stock and bought 74 units worth $743 . The most active insiders traders include Edgar Jr Bronfman, Jeffrey D Jordan et Dawn G Lepore. On average, Accolade executives and independent directors trade stock every 5 days with the average trade being worth of $18,928. The most recent stock trade was executed by Rajeev Singh on 3 September 2024, trading 3,786 units of ACCD stock currently worth $14,803.

What does Accolade do?

Accolade, Inc., together with its subsidiaries, develops and provides technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based technology and multimodal support from a team of health assistants and clinicians, including nurses, physician medical directors, and behavioral health specialists. It also provides second opinion consultation and health care decision support services. The company serves employers who provide their employees and their employees' families a single place to turn for their health, healthcare, and benefits needs. Accolade, Inc. was incorporated in 2007 and is headquartered in Plymouth Meeting, Pennsylvania.

Complete history of Colin Hugh stock trades at Accolade

Accolade executives and stock owners

Accolade executives and other stock owners filed with the SEC include:

• Rajeev Singh,
  Chairman & CEO
• Robert Cavanaugh,
  Pres
• Stephen H. Barnes CPA,
  CFO & Treasurer
• Michael W. Hilton,
  Chief Innovation Officer
• Jennifer Hanson,
  Exec. VP of People and Culture & Chief HR Officer
• Britt Provost,
  Exec. VP of People & Culture
• Carolina Lobo,
  Chief Marketing Officer
• Phong Nguyen,
  Chief Operating Officer
• William S. Morrison,
  Sr. VP of Strategy & Corp. Devel.
• Richard Eskew,
  Exec. VP, Gen. Counsel & Chief Privacy Officer
• Todd Friedman,
  Sr. VP of Investor Relations
• Harish Naidu,
  Chief Technology Officer
• David Wyatt,
  Exec. VP of Operations
• Stephen H. Barnes,
  CFO, Treasurer & Sec.
• J. Michael Cline,
  Co-Founder & Independent Chairman
• Dawn G Lepore,
  Director
• Patricia L Wadors,
  Director
• William H. Frist,
  Director
• Jeffrey D Jordan,
  Director
• Thomas J Neff,
  Director
• Capital Partners Ii Co Inve...,
  
• James C. Madden,
  
• Parallel Fund Iv, L.P.Ah Pa...,
  
• Horowitz Fund Iv, L.P.Andre...,
  
• J Michael Cline,
  Director
• Edgar Jr Bronfman,
  
• Rajeev Singh,
  Chief Executive Officer
• Stephen H. Barnes,
  Chief Financial Officer
• Robert N Cavanaugh,
  President
• Cindy Kent,
  Director
• Jeffrey S Brodsky,
  Director
• Elizabeth G Nabel,
  Director
• Peter S Klein,
  Director
• Michael W Hilton,
  Director
• Richard Eskew,
  EVP General Counsel
• Colin Mc Hugh,
  Chief Accounting Officer